Proton beam stereotactic radiosurgery for pediatric cerebral arteriovenous malformations

Neurosurgery

Volumn 74, Issue 4, 2014, Pages 367-373

  Walcott, Brian P ^a   Hattangadi Gluth, Jona A ^b   Stapleton, Christopher J ^a   Ogilvy, Christopher S ^c   Chapman, Paul H ^a   Loeffler, Jay S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arteriovenous; AVM; Bragg peak; Pediatric; Proton; Radiosurgery; Stereotactic

Indexed keywords

ADOLESCENT; ARTICLE; BLEEDING; BRAIN ARTERIOVENOUS MALFORMATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MALE; MAXIMUM PERMISSIBLE DOSE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PAIN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION DOSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; STEREOTACTIC RADIOSURGERY; TREATMENT RESPONSE; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; PROCEDURES; PROTON THERAPY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; PROTON THERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84897446032     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000294     Document Type: Article

References (46)

1. Wedderburn CJ, van Beijnum J, Bhattacharya JJ, et al. Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study. Lancet Neurol. 2008;7(3):223-230.
2. Pollock BE, Flickinger JC, Lunsford LD, Bissonette DJ, Kondziolka D. Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke. 1996;27(1):1-6.
3. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990;73(3):387-391.
4. Brown RD Jr, Wiebers DO, Forbes G, et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg. 1988;68(3):352-357.
5. Stapf C, Mast H, Sciacca R, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006;66(9):1350-1355.
6. Forster DM, Steiner L, Håkanson S. Arteriovenous malformations of the brain: a long-term clinical study. J Neurosurg. 1972;37(5):562-570.
7. Codd PJ, Mitha AP, Ogilvy CS. A recurrent cerebral arteriovenous malformation in an adult. J Neurosurg. 2008;109(3):486-491.
8. Jayaraman M, Marcellus M, Hamilton S, et al. Neurologic complications of arteriovenous malformation embolization using liquid embolic agents. AJNR Am J Neuroradiol. 2008;29(2):242-246.
9. Ledezma CJ, Hoh BL, Carter BS, Pryor JC, Putman CM, Ogilvy CS. Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery. 2006;58(4):602-611.
10. Wallace RC, Flom RA, Khayata MH, et al. The safety and effectiveness of brain arteriovenous malformation embolization using acrylic and particles: the experiences of a single institution. Neurosurgery. 1995;37(4):606-618.
11. Van Rooij W, Sluzewski M, Beute G. Brain AVM embolization with Onyx. AJNR Am J Neuroradiol. 2007;28(1):172-177.
12. Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology. 2008;50(7):589-597.
13. Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M, Wanke I. Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol. 2009;30(1):99-106.
14. Barr JC, Ogilvy CS. Selection of treatment modalities or observation of arteriovenous malformations. Neurosurg Clin N Am. 2012;23(1):63-75.
15. Cohen-Gadol AA, Pollock BE. Radiosurgery for arteriovenous malformations in children. J Neurosurg Pediatr. 2006;104(6 suppl):388-391.
16. Smyth MD, Sneed PK, Ciricillo SF, et al. Stereotactic radiosurgery for pediatric intracranial arteriovenous malformations: the University of California at San Francisco experience. J Neurosurg. 2002;97(1):48-55.
17. Shin M, Kawamoto S, Kurita H, et al. Retrospective analysis of a 10-year experience of stereotactic radiosurgery for arteriovenous malformations in children and adolescents. J Neurosurg. 2002;97(4):779-784.
18. Pan DH-C, Kuo Y-H, Guo W-Y, et al. Gamma Knife surgery for cerebral arteriovenous malformations in children: a 13-year experience. J Neurosurg Pediatr. 2008;1(4):296-304.
19. Dinca EB, de Lacy P, Yianni J, et al. Gamma Knife surgery for pediatric arteriovenous malformations: a 25-year retrospective study: clinical article. J Neurosurg Pediatr. 2012;10(5):445-450.
20. Kjellberg RN, Hanamura T, Davis KR, Lyons SL, Adams RD. Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med. 1983; 309(5):269-274.
21. Durante M, Loeffler JS. Charged particles in radiation oncology. Nat Rev Clin Oncol. 2009;7(1):37-43.
22. Grün R, Friedrich T, Elsässer T, et al. Impact of enhancements in the local effect model (LEM) on the predicted RBE-weighted target dose distribution in carbon ion therapy. Phys Med Biol. 2012;57(22):7261.
23. Dennis ER, Bussiere MR, Niemierko A, et al. A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy. Technol Cancer Res Treat. 2012; 12(1):1-9.
24. Arvold ND, Niemierko A, Broussard GP, et al. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma. Int J Radiat Oncol Biol Phys. 2012;83(4):e495-e500.
25. Chen CC, Chapman P, Petit J, Loeffler J. Proton radiosurgery in neurosurgery. Neurosurg Focus. 2007;23(6):E5.
26. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53(2): 407-421.
27. Barker FG, Butler WE, Lyons S, et al. Dose-volume prediction of radiation-related complications after proton beam radiosurgery for cerebral arteriovenous malformations. J Neurosurg. 2003;99(2):254-263.
28. Wegner RE, Oysul K, Pollock BE, et al. A modified radiosurgery-based arteriovenous malformation grading scale and its correlation with outcomes. Int J Radiat Oncol Biol Phys. 2011;79(4):1147-1150.
29. Pollock BE, Flickinger JC. Modification of the radiosurgery-based arteriovenous malformation grading system. Neurosurgery. 2008;63(2):239-243.
30. Mast H, Young WL, Koennecke H-C, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350(9084): 1065-1068.
31. da Costa L, Wallace MC, ter Brugge KG, O'Kelly C, Willinsky RA, Tymianski M. The natural history and predictive features of hemorrhage from brain arteriovenous malformations. Stroke. 2009;40(1):100-105.
32. Marks M, Lane B, Steinberg G, Chang P. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology. 1990;176 (3):807-813.
33. Loeffler JS, Niemierko A, Chapman PH. Second tumors after radiosurgery: tip of the iceberg or a bump in the road? Neurosurgery. 2003;52(6):1436-1442.
34. Flickinger JC, Pollock BE, Kondziolka D, Lunsford LD. A dose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys. 1996;36(4):873-879.
35. Flickinger JC, Kondziolka D, Maitz AH, Dade Lunsford L. An analysis of the dose-response for arteriovenous malformation radiosurgery and other factors affecting obliteration. Radiother Oncol. 2002;63(3):347-354.
36. Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352(2):146-153.
37. Hattangadi JA, Chapman PH, Bussière MR, et al. Planned two-fraction proton beam stereotactic radiosurgery for high-risk inoperable cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2012;83(2):533-541.
38. Suit H, Goldberg S, Niemierko A, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol. 2003;42(8):800-808.
39. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002;54(3):824-829.
40. St Clair W, Adams J, Bues M, et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys. 2004;58(3):727-734.
41. Suit H, Kooy H, Trofimov A, et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol. 2008;86(2):148-153.
42. Loeffler JS, Durante M. Charged particle therapy-optimization, challenges and future directions. Nat Rev Clin Oncol. 2013.
43. Potts MB, Young WL, Lawton MT. Deep arteriovenous malformations in the basal ganglia, thalamus, and insula: microsurgical management, techniques, and results. Neurosurgery. 2013;73(3):417-429.
44. Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg. 2003;98(1):3-7.
45. O'Connor TE, Friedman WA. Magnetic resonance imaging assessment of cerebral arteriovenous malformation obliteration after stereotactic radiosurgery. Neurosur-gery. 2013;73(5):761-766.
46. Pollock BE, Kondziolka D, Flickinger JC, Patel AK, Bissonette DJ, Lunsford LD. Magnetic resonance imaging: an accurate method to evaluate arteriovenous malformations after stereotactic radiosurgery. J Neurosurg. 1996; 85(6):1044-1049.